Merck & Co., Inc. (ETR:6MK)
Germany · Delayed Price · Currency is EUR 75.00
-0.50 (-0.66%)
Oct 10, 2025, 5:35 PM CET
Merck & Co. Employees
As of December 31, 2024, Merck & Co. had 75,000 total employees, including 73,000 full-time and 2,000 part-time employees. The number of employees increased by 3,000 or 4.17% compared to the previous year.
Employees
75,000
Change (1Y)
3,000
Growth (1Y)
4.17%
Revenue / Employee
€732,014
Profits / Employee
€188,780
Market Cap
184.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75,000 | 3,000 | 4.17% |
| Dec 31, 2023 | 72,000 | 3,000 | 4.35% |
| Dec 31, 2022 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2021 | 68,000 | -6,000 | -8.11% |
| Dec 31, 2020 | 74,000 | 3,000 | 4.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,730 |
Merck & Co. News
- 1 day ago - High Margins, Lower Price: Is This Merck Stock's Buying Window? - Forbes
- 2 days ago - Behind the Scenes of Merck & Co's Latest Options Trends - Benzinga
- 2 days ago - Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025 - Wallstreet:Online
- 2 days ago - Merck to Present New Data from HIV Treatment and Prevention Pipeline at European AIDS Conference 2025 - Business Wire
- 2 days ago - Merck Advances Oncology Innovation, Highlighting Progress in New Tumor Types and Earlier Stages of Disease at ESMO 2025 - Business Wire
- 3 days ago - MERCK INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 3 days ago - Vaccine debate heats up as officials weigh splitting combined MMR into single doses - Fox News
- 4 days ago - Merck (MRK) Declines More Than Market: Some Information for Investors - Nasdaq